Quest Laboratories

Quest Laboratories EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Laboratories (QUESTLAB.NS) as of Oct 19, 2026 is -8.22. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 71.58 — a change of -111.48% (lower).

EV/OCF

-8.22

YoY

-111.48%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Laboratories is 2025 -8.22 . EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Laboratories was 2024 71.58 . It decreases by -111.48% lower compared to the previous year.

The Quest Laboratories EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2023
58.48 INR
Jan 1, 2024
71.58 INR
Jan 1, 2025
-8.22 INR
The Quest Laboratories EV/OCF history
YEAREV/OCFYoY
-8.22-111.48%
71.58+22.38%
58.48—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quest Laboratories Stock analysis

What does Quest Laboratories do? Quest Laboratories Ltd is an Indian pharmaceutical manufacturer headquartered in Dhar, Madhya Pradesh, which listed its shares on the stock exchange on 23 May 2024. The company produces a wide range of pharmaceutical formulations, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants. Its product portfolio encompasses ethical drugs, generic medicines, and over-the-counter items, available in diverse forms such as tablets, liquid orals, oral dry powders, oral rehydration salts, ointments, and external liquids. Specific offerings include Cetirizine Hydrochloride and Diclofenac Sodium tablets, as well as Ferrous Sulphate & Folic Acid syrup and Albendazole suspension. The firm also manufactures Silver Sulphadiazine cream and Diclofenac Diethylamino gel. By manufacturing these varied therapeutic agents, Quest Laboratories serves the domestic healthcare market with a focus on accessible and essential medicinal products. The company’s operations are centered on the production and distribution of these critical health care solutions within India. Quest Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quest Laboratories stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Laboratories is -8.22 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Quest Laboratories changed from 71.58 to -8.22, representing a -111.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Quest Laboratories since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Quest Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Quest Laboratories

All Key Metrics — Quest Laboratories